A recent study, published as a preprint on Nature Communications and authored by a research team affiliated with various institutions in China, has sparked significant discussion within the scientific and health communities. The research, titled "Exogenous creatine supplementation promotes tumor metastasis via megakaryocyte creatine kinase B-STAT5B signaling," posits a link between creatine supplementation and the increased metastasis of certain cancerous tumors. However, experts are urging caution, emphasizing that the study’s conclusions, particularly as presented in its headline, may extend beyond the scope of its findings.
The core of the research delves into the intricate role of creatine within platelets and megakaryocytes (MKs), the precursor cells in bone marrow responsible for platelet production. The researchers hypothesized that alterations in MKs could lead to the generation of platelets with atypical functions, potentially influencing cancer cell dissemination. This investigation builds upon the same research group’s prior work exploring the impact of glucose and ketone metabolism within MKs and their subsequent effect on platelet behavior. Their objective in this study was to specifically examine creatine’s influence in this context, investigating whether elevated creatine levels might induce MKs to produce platelets that facilitate cancer cell migration through the bloodstream to secondary sites, thereby evading immune surveillance.
To explore this hypothesis, the researchers employed a multifaceted experimental design involving various mouse models. In a significant portion of the study, mice were administered a clinically relevant dose of creatine monohydrate. Following supplementation, blood was drawn, and platelets were isolated for in vitro analysis to assess their interaction with cancer cells. Concurrently, an in vivo experiment was conducted by directly injecting cancer cells into the tail veins of these supplemented mice to observe the rate of tumor cell travel within their circulatory systems. The research team also utilized crossbreeding techniques to isolate specific genetic factors potentially involved in the cell signaling pathways under investigation, aiming to control for genetic variability.
The findings from the murine component of the study indicated that exogenous creatine supplementation led to the production of what the researchers termed "hyperactive" and "pro-metastatic" platelets. This suggests that the increased presence of creatine influenced platelet function in a way that could promote cancer cell spread.
Adding a human element to the research, the study included a cohort of 11 human subjects. These participants were given a high dosage of 20 grams per day of creatine monohydrate for a period of two weeks. The primary aim of this human arm was to gather comparative data alongside the murine experiments. The researchers reported that this high-dose supplementation in humans also resulted in the production of "hyperactive" and "pro-metastatic" platelets. To further validate their findings, platelets collected from these human volunteers were then introduced into immunodeficient mice. This experiment replicated the observed boost in metastasis seen in the mouse-only experiments, lending some weight to the potential relevance of the findings to human physiology.
The authors of the study suggested that their findings could potentially influence current recommendations for creatine supplementation, particularly for cancer patients. While exercise is often encouraged for individuals undergoing cancer treatment, the use of creatine to enhance physical performance might warrant reconsideration in light of these new observations.
Expert Perspectives: Nuance and Caution
Despite the attention-grabbing nature of the study’s title, independent experts have voiced reservations, advocating for a more nuanced interpretation of the findings. Susan Hewlings, Ph.D., principal at Substantiation Sciences, highlighted several critical points. She noted that the mechanistic models used in the mouse studies involved "forced" metastasis, where cancer cells were directly injected into the bloodstream. This artificial method, she argued, does not accurately reflect the natural process of metastasis in humans.
Furthermore, Hewlings pointed out the limitations of the human data. The study participants were healthy young adults, who may not be representative of older individuals who are statistically more prone to developing cancer. Additionally, the dosage of 20 grams per day for two weeks is significantly higher than the commonly recommended maintenance doses, which typically range from 3 to 5 grams per day after an initial loading phase of a few days. "To say creatine causes tumor growth is a huge stretch and it goes against a large existing safety record," Hewlings stated. She referenced the International Society of Sports Nutrition’s 2017 position stand and numerous systematic reviews, which collectively support the safety of creatine in healthy adults over extended periods of use. She emphasized that a single mechanistic study, regardless of its laboratory rigor, cannot overturn this substantial body of evidence.
Wayne Heidenreich, M.D., former chief medical officer of Northwestern Mutual Life Insurance Co., echoed these sentiments. He agreed that the paper could be subject to misinterpretation but acknowledged its potential to offer insights for clinicians. "There is no evidence that creatine causes cancer. In fact, it may help protect one from the development of a primary tumor. Clinical studies have not proven an increase in the frequency of metastatic disease in humans," Heidenreich asserted.
He advised caution for individuals with a history of primary cancers, such as breast, colon, or prostate cancer. He recommended that the disclosure of creatine use should serve as an opportunity to reinforce the importance of diligent cancer screening according to clinical guidelines for all individuals, regardless of supplement use.
Background and Context of Creatine Research
Creatine, a naturally occurring compound found in muscle cells, plays a vital role in energy production, particularly during short bursts of high-intensity activity. It is synthesized in the liver, kidneys, and pancreas and is also obtained from dietary sources like red meat and fish. For decades, creatine monohydrate has been one of the most widely researched and utilized dietary supplements, primarily for its ergogenic benefits in athletic performance, muscle strength, and power.
The International Society of Sports Nutrition (ISSN) has published comprehensive position stands on creatine, consistently affirming its efficacy and safety for healthy individuals when used as directed. These position stands are based on a vast accumulation of scientific literature, including numerous randomized controlled trials, meta-analyses, and systematic reviews spanning over two decades. They address various aspects of creatine supplementation, including its impact on performance, body composition, cognitive function, and its safety profile across different age groups and populations.
Research has also explored potential therapeutic applications of creatine beyond sports performance. Studies have investigated its role in neurological disorders, muscle wasting conditions, and age-related decline. However, the predominant body of research has focused on its benefits for exercise performance and muscle health.
The Nature of Preprints and Scientific Scrutiny
The decision to release this study as a preprint on Nature Communications is a significant factor in understanding its current standing. Preprints are research papers that have not yet undergone formal peer review by the scientific community. While they allow for rapid dissemination of new findings and can accelerate scientific progress by enabling early feedback, they also mean that the research has not been independently vetted for accuracy, methodology, or interpretation by experts in the field.
The scientific process relies heavily on peer review to ensure the quality and validity of published research. Once a preprint is released, it is typically submitted to a peer-reviewed journal for formal evaluation. During the peer-review process, external scientists with expertise in the subject matter critically assess the study’s design, execution, data analysis, and conclusions. They may suggest revisions, request further clarification, or even reject the paper if they find significant flaws.
In the case of this creatine study, the preprint format has allowed for immediate public access to the findings, leading to both widespread interest and immediate expert commentary. This situation highlights the dynamic nature of scientific discovery, where initial findings often spark debate and further investigation before definitive conclusions can be drawn.
Implications for the Supplement Industry and Consumers
The study’s findings, even with expert caveats, are likely to have implications for the supplement industry and its consumers. Creatine is a staple in many sports nutrition formulations, and any suggestion of potential negative health impacts, however preliminary, can generate concern.
For supplement manufacturers and retailers, this study underscores the importance of clear and accurate product labeling and marketing. It emphasizes the need to avoid making unsubstantiated health claims and to provide consumers with balanced information about the potential benefits and risks of their products. The industry has a responsibility to stay abreast of evolving scientific research and to communicate findings transparently.
For consumers, this research serves as a reminder to approach health information critically. It is crucial to distinguish between preliminary research findings, especially those from preprints, and well-established scientific consensus. Consulting with healthcare professionals before starting any new supplement regimen, particularly for individuals with pre-existing health conditions or those undergoing medical treatment, remains paramount.
The study’s authors themselves noted that their findings could alter recommendations for creatine supplementation in cancer patients. This suggests a potential shift in how creatine is viewed within the clinical oncology setting, where the balance of benefits and risks needs careful consideration. While exercise is widely recognized as beneficial for cancer patients, the role of performance-enhancing supplements like creatine warrants further investigation in this vulnerable population.
Future Directions and Research Needs
The current study, while provocative, opens the door for significant future research. Key areas for further investigation include:
- Replication and Extension of Human Studies: Larger, more diverse human trials are needed to confirm the findings observed in the small cohort. These studies should include individuals of various ages, health statuses, and cancer histories.
- Mechanistic Elucidation: A deeper understanding of the precise molecular pathways through which creatine influences megakaryocytes and platelets is crucial. Investigating the role of creatine kinase B and the STAT5B signaling pathway in more detail could reveal specific therapeutic targets.
- Dosage and Duration Studies: Research is needed to determine the specific dosages and durations of creatine supplementation that might be associated with these observed effects, and conversely, to identify safe limits for general populations and potentially for specific patient groups.
- Long-Term Safety and Efficacy: Given the extensive history of creatine use and its generally accepted safety profile, future studies should aim to reconcile these new findings with existing knowledge, potentially by investigating whether specific genetic predispositions or co-existing health conditions might mediate any adverse effects.
- Clinical Relevance: The ultimate goal will be to determine the real-world clinical significance of these findings. Does the observed increase in metastasis in animal models translate into a measurable increase in cancer progression in humans?
In conclusion, the study linking creatine supplementation to increased tumor metastasis is a significant piece of research that demands careful consideration. While it raises important questions about the complex interplay between nutrition, cellular biology, and cancer progression, the preliminary nature of the findings and the criticisms raised by experts necessitate a measured response. The scientific community awaits further validation and clarification through rigorous peer review and subsequent research to fully understand the implications of these findings for creatine use and cancer biology.
